REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 392 filers reported holding REPLIGEN CORP in Q3 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $183,371,195 | +1.8% | 1,153,205 | -9.4% | 0.06% | +7.1% |
Q2 2023 | $180,098,541 | +0.4% | 1,273,141 | +19.5% | 0.06% | -5.1% |
Q1 2023 | $179,325,454 | -2.3% | 1,065,131 | -1.8% | 0.06% | -6.3% |
Q4 2022 | $183,612,000 | -12.8% | 1,084,468 | -3.7% | 0.06% | -19.2% |
Q3 2022 | $210,604,000 | -0.9% | 1,125,571 | -13.9% | 0.08% | +5.4% |
Q2 2022 | $212,422,000 | -16.6% | 1,308,034 | -3.4% | 0.07% | -1.3% |
Q1 2022 | $254,817,000 | -19.7% | 1,354,760 | +13.0% | 0.08% | -14.8% |
Q4 2021 | $317,460,000 | +52.8% | 1,198,675 | +66.8% | 0.09% | +33.3% |
Q3 2021 | $207,709,000 | +46.0% | 718,681 | +0.8% | 0.07% | +50.0% |
Q2 2021 | $142,301,000 | +104.3% | 712,862 | +98.9% | 0.04% | +91.3% |
Q1 2021 | $69,670,000 | -41.0% | 358,379 | -41.8% | 0.02% | -45.2% |
Q4 2020 | $118,019,000 | +23.4% | 615,869 | -5.0% | 0.04% | +7.7% |
Q3 2020 | $95,668,000 | +54.2% | 648,413 | +29.2% | 0.04% | +44.4% |
Q2 2020 | $62,030,000 | -1.8% | 501,809 | -23.3% | 0.03% | -18.2% |
Q1 2020 | $63,176,000 | +130.7% | 654,403 | +121.1% | 0.03% | +200.0% |
Q4 2019 | $27,383,000 | +17.7% | 296,034 | -2.4% | 0.01% | +10.0% |
Q3 2019 | $23,270,000 | -40.7% | 303,433 | -33.6% | 0.01% | -44.4% |
Q2 2019 | $39,257,000 | +42.4% | 456,753 | -2.1% | 0.02% | +38.5% |
Q1 2019 | $27,576,000 | -18.2% | 466,761 | -27.0% | 0.01% | -23.5% |
Q4 2018 | $33,710,000 | -32.1% | 639,168 | -28.6% | 0.02% | 0.0% |
Q3 2018 | $49,649,000 | +17.6% | 895,252 | -0.2% | 0.02% | -10.5% |
Q2 2018 | $42,213,000 | +50.2% | 897,391 | +15.6% | 0.02% | +46.2% |
Q1 2018 | $28,097,000 | +47.3% | 776,567 | +47.7% | 0.01% | +44.4% |
Q4 2017 | $19,073,000 | +19.9% | 525,722 | +26.7% | 0.01% | +12.5% |
Q3 2017 | $15,902,000 | -8.5% | 414,961 | -1.1% | 0.01% | -11.1% |
Q2 2017 | $17,386,000 | +17.2% | 419,561 | -0.5% | 0.01% | +12.5% |
Q1 2017 | $14,838,000 | +8.2% | 421,539 | -5.2% | 0.01% | +14.3% |
Q4 2016 | $13,708,000 | -15.3% | 444,785 | -17.0% | 0.01% | -22.2% |
Q3 2016 | $16,185,000 | -1.9% | 536,122 | -11.1% | 0.01% | -10.0% |
Q2 2016 | $16,492,000 | +16.1% | 602,779 | +13.8% | 0.01% | +25.0% |
Q1 2016 | $14,206,000 | -21.6% | 529,657 | -17.3% | 0.01% | -27.3% |
Q4 2015 | $18,113,000 | +5.0% | 640,255 | +3.3% | 0.01% | 0.0% |
Q3 2015 | $17,258,000 | -39.5% | 619,645 | -10.3% | 0.01% | -31.2% |
Q2 2015 | $28,514,000 | +24.8% | 690,919 | -8.2% | 0.02% | +23.1% |
Q1 2015 | $22,855,000 | +10.1% | 752,796 | -28.2% | 0.01% | +8.3% |
Q4 2014 | $20,756,000 | +4.2% | 1,048,254 | +4.8% | 0.01% | 0.0% |
Q3 2014 | $19,919,000 | -13.0% | 1,000,351 | -0.4% | 0.01% | -14.3% |
Q2 2014 | $22,898,000 | +130.3% | 1,004,840 | +29.9% | 0.01% | +133.3% |
Q1 2014 | $9,944,000 | -8.0% | 773,299 | -2.4% | 0.01% | -14.3% |
Q4 2013 | $10,805,000 | +15.1% | 792,182 | -6.4% | 0.01% | +16.7% |
Q3 2013 | $9,389,000 | +51.4% | 846,646 | +12.5% | 0.01% | +50.0% |
Q2 2013 | $6,200,000 | – | 752,413 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |